Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/1998
02/11/1998CN1173175A Substituted 2 -arylcaronyloxymethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1-dioxide derivatives and compositions and method of use thereof
02/11/1998CN1173131A 2 -(2, 3, 5, 6 -tetrafluoro -4 -phridyl) -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof
02/11/1998CN1173130A 2 -heterocyclyloxy and thiomethyl -1, 2, 5 -thiadiazolidin -3 -one 1, 1 -dioxides and compositions and method of use thereof
02/11/1998CN1172805A Process for preparation of unsymmetrical 4, 6-bis (aryloxy) pyrimidine compounds
02/11/1998CN1037349C Fluoropropylthiazoline derivative and herbicide
02/10/1998US5717102 Psychotherapeutics; headaches
02/10/1998US5717100 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
02/10/1998US5717097 HIV protease inhibitors useful for the treatment of AIDS
02/10/1998US5717079 Containing at least two 1,3-sulfur-nitrogen moieties and a complete dye or dye intermediate
02/10/1998US5716979 Tachykinin antagonists
02/10/1998US5716975 Nontoxic rhodanine derivatives; antidiabetic agents, cathepsin d inhibitors, b-amyloid protein reduction
02/10/1998US5716967 Isoxazoline compounds as antiinflammatory agents
02/10/1998US5716949 Heterocyclic compounds
02/10/1998US5716906 Saccharin derivatives
02/05/1998WO1998004913A1 Molecular model for vla-4 inhibitors
02/05/1998WO1998004555A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
02/05/1998WO1998004554A1 Chemokine receptor antagonists
02/05/1998WO1998004544A1 New liquid crystal compounds and their precursors
02/05/1998WO1998004536A1 Thiazole derivative as protein kinase c inhibitors
02/05/1998WO1998004534A1 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and medicinal compositions containing the same
02/05/1998WO1998004532A1 Fungicidal aryl-substituted five-membered heterocylic compounds
02/05/1998WO1998004528A2 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
02/05/1998WO1998004526A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
02/05/1998WO1998004247A1 Cell adhesion inhibitors
02/05/1998CA2262434A1 Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
02/05/1998CA2261974A1 Molecular model for vla-4 inhibitors
02/05/1998CA2261633A1 Chemokine receptor antagonists
02/05/1998CA2261167A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
02/05/1998CA2258609A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
02/05/1998CA2233611A1 Thiazole derivative
02/04/1998EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
02/04/1998EP0822186A2 L-tert-leucine-2-pyridylamide
02/04/1998EP0821959A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal
02/04/1998EP0821958A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression
02/04/1998EP0821957A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
02/04/1998EP0821956A1 Method for treating disruptive behavior disorders
02/04/1998EP0821955A2 Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating bipolar disorder
02/04/1998EP0821954A1 Method for treating mental retardation
02/04/1998EP0821684A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
02/04/1998EP0821683A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
02/04/1998EP0821682A1 Benzimidazole compounds and their use as modulators of the gaba a? receptor complex
02/04/1998EP0821677A1 Oxazoline and thiazoline arthropodicides
02/04/1998EP0821675A1 Novel hydroxamic acid and amino-carboxylate compounds as metalloprotease and tnf inhibitors
02/04/1998EP0821674A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
02/04/1998EP0821671A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
02/04/1998EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
02/04/1998EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE
02/04/1998CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
02/04/1998CN1172111A 1, 2, 3 -benzothiadiazole derivatives
02/04/1998CN1037268C Method for preparation of antipicornaviral phridazinamines
02/04/1998CN1037267C Method for preparation of tri-substituted tetrahydrofuran derivative
02/03/1998US5714614 Azo-methine dyes which form lightfast images
02/03/1998US5714609 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
02/03/1998US5714606 Pyrrolidine-containing monomers and oligomers
02/03/1998US5714503 Compounds and methods for inhibition of HIV and related viruses
02/03/1998US5714492 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same
02/03/1998US5714488 For treatment of allergic and inflammatory disease states
02/03/1998US5714479 Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
02/03/1998US5714437 Weed extermination; morning glories, velvet leaf plants, barnyard grass
01/1998
01/29/1998WO1998003610A1 Liquid crystalline saccharose derivatives
01/29/1998WO1998003500A1 Carbanilides used as pesticides
01/29/1998WO1998003490A1 Intermediates for the preparation of 2-imidazoline-5-ones
01/29/1998WO1998003487A1 Compounds, compositions and methods for treating influenza
01/29/1998WO1998003166A1 Thiol sulfonamide metalloprotease inhibitors
01/29/1998WO1997043282A3 Benzothiazolinones as anti-asthmatic agents
01/29/1998DE19630068A1 Neue flüssigkristalline Verbindungen und deren Vorprodukte New liquid crystalline compounds and their precursors
01/29/1998DE19629828A1 Carbanilide Carbanilides
01/29/1998CA2260860A1 Thiol sulfonamide metalloprotease inhibitors
01/29/1998CA2260799A1 Compounds, compositions and methods for treating influenza
01/28/1998EP0820607A1 Photographic system
01/28/1998EP0820452A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
01/28/1998EP0820448A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
01/28/1998EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS
01/28/1998CN1171793A Gas phase polymerization process
01/27/1998US5712300 Hydroxamic acid derivatives useful for the treatment of diseases related to connective tissue degradation
01/27/1998US5712299 (1-phenyl-1-heterocyclyl)methanol and (1-phenyl-1-heterocyclyl methylamine derivatives
01/27/1998US5712297 Piperdine compounds and their preparation and use
01/27/1998US5712292 N-substituted azaheterocyclic carboxylic acids and esters thereof
01/27/1998US5712291 Methods and compositions for inhibition of angiogenesis
01/27/1998US5712279 Inhibitors of microsomal triglyceride transfer protein and method
01/27/1998US5712270 2-arylamidothiazole derivatives with CNS activity
01/27/1998US5712266 Cephalosporins
01/22/1998WO1998002436A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998WO1998002433A1 Certain fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
01/22/1998WO1998002420A1 Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
01/22/1998WO1998002159A1 Novel treatment of leptine resistance
01/22/1998DE19628700A1 Flüssigkristalline Zuckerderivate Liquid crystalline sugar derivatives
01/22/1998CA2260216A1 Thiadioxobenzodiazepine inhibitors of farnesyl protein transferase
01/22/1998CA2260044A1 Novel treatment of leptine resistance
01/21/1998EP0819692A1 Kojic acid derivative as depigmentation agent
01/21/1998EP0819681A2 N-(4-Aryl-thiazol-2-yl)-sulfonamides and their use
01/21/1998EP0819133A2 Covalently linked oligonucleotide minor groove binder conjugates
01/21/1998EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
01/21/1998CN1171110A Production of cefotaxime and new sodium salts
01/21/1998CN1170575A Treatment and prophylaxis of pancreatitis
01/20/1998US5710169 Therapeutic heterocycles
01/20/1998US5710167 Hydroxamic acid derivatives with tricyclic substitution for treating degenerative joint diseases
01/20/1998US5710159 Integrin receptor antagonists
01/20/1998US5710153 Tetrazole compound
01/20/1998US5710152 Benzoazine derivative or salt thereof and pharmaceutical compostion comprising the same